Cleveland Biolabs (CBLI) Reports Q1 Loss of $0.06/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Total operating expenses: 1.86M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Total operating expenses: 1.86M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q1 EPS of ($0.06), versus ($1.14) reported last year. Revenue for the quarter came in at $12.5 thousand, versus $607.3 thousand reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- UBS Reiterates Buy Rating on Pepsico (PEP) on Q3 Beat
- Bernstein SocGen: 'MediaTek Inc. (2454:TT) (MDTKF) is our Top Pick and the recent pullback provides a good setup'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
